| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,987 |
10,487 |
$759K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,683 |
6,677 |
$561K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,591 |
8,139 |
$457K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,415 |
7,401 |
$419K |
| 99058 |
|
2,648 |
2,472 |
$168K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
851 |
813 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
780 |
774 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
877 |
852 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
135 |
135 |
$3K |
| 81002 |
|
1,434 |
1,420 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
42 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
33 |
32 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
108 |
108 |
$808.89 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$371.60 |
| 99001 |
|
49 |
47 |
$352.89 |
| 87428 |
|
14 |
14 |
$295.00 |
| 99000 |
|
110 |
108 |
$246.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
357 |
345 |
$201.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
29 |
$170.56 |
| 84703 |
|
29 |
29 |
$43.71 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
38 |
$27.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
71 |
71 |
$26.69 |